Buscar
Congreso SOLACI

Búsqueda de: Stent

Si no está conforme con los resultados, inténtelo de nuevamente.
Coronary disease

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to...
Dr. Andrés Rodríguez -
Ir
Chronic Coronary Syndromes

Plaque Morphology and Stent Elongation Assessed by OCT

Second and third generation drug eluting stents (DES) have thin or ultrathin struts and a scaffold that...
Dr. Omar Tupayachi -
Ir
Acute coronary syndromes

Results of the PROSPECT II Substudy: Relationship Between In-Stent or Stent Edge-Related Lipid-Rich Plaque and Adverse Clinical Events After PCI in Patients with MI

The use of drug-eluting stents and the integration of intravascular imaging techniques have reduced the risk of...
Dr. Andrés Rodríguez -
Ir
Antiplatelet

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which...
Dr. Andrés Rodríguez -
Ir
Chronic Coronary Syndromes

Long Term Outcomes of RIBS VI, a Study on Bioresorbable Stents in Patients with In-Stent Restenosis

The use of drug eluting stents (DES) is currently recommended for the percutaneous treatment of coronary artery...
Dr. Andrés Rodríguez -
Ir
Coronary disease

IVUS Optimized Left Main 2-Stent Strategy: Should We Drop the 5-6-7-8 Criterion?

Provisional stenting in bifurcations has shown better results at mid and long term vs initial two stent...
Dr. Omar Tupayachi -
Ir
Chronic Coronary Syndromes

ESC 2024 | REC-CAGEREE I Trial: Drug Coated Balloon with Bailout Stenting vs. Intended DES for de Novo Lesion Treatment

DES stenting is currently the standard treatment. The development of balloon technology and the coating drugs have...
Dr. Omar Tupayachi -
Ir
Chronic Coronary Syndromes

EMPIRE Trial: Is Microvascular Protection Feasible in PCI Depending on the Stenting Technique?

Percutaneous coronary intervention (PCI) may entail inherent complications, such as a diagnosis of periprocedural myocardial infarction (MI...
solaci -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad